Advisor Group, Inc. - AXOVANT GENE THERAPIES LTD ownership

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 50 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q4 2019$0800.0%0.00%
Q3 2019$0800.0%0.00%
Q2 2019$0800.00%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2019.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders